Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 443 entries
Sorted by: Best Match Show Resources per page
WITHDRAWN: Sensitive and Accurate Simultaneous Measurement of Estrone, Estradiol, Dehydroepiandrosterone, Androst-5-ene-3 beta, 17 beta diol, Androstenedione, Testosterone and Dihydrotestosterone in Postmenopausal Women Serum by a Robust LC-MS/MS Validated Assay using a Single Sample Preparation Method.

Steroids

Ke Y, Bertin J, Gonthier R, Simard JN, Labrie F.
PMID: 25159106
Steroids. 2014 Aug 23; doi: 10.1016/j.steroids.2014.08.001. Epub 2014 Aug 23.

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Cite
Ke Y, Bertin J, Gonthier R, et al. WITHDRAWN: Sensitive and Accurate Simultaneous Measurement of Estrone, Estradiol, Dehydroepiandrosterone, Androst-5-ene-3 beta, 17 beta diol, Androstenedione, Testosterone and Dihydrotestosterone in Postmenopausal Women Serum by a Robust LC-MS/MS Validated Assay using a Single Sample Preparation Method. Steroids. 2014;doi: 10.1016/j.steroids.2014.08.001.
Ke, Y., Bertin, J., Gonthier, R., Simard, J. N., & Labrie, F. (2014). WITHDRAWN: Sensitive and Accurate Simultaneous Measurement of Estrone, Estradiol, Dehydroepiandrosterone, Androst-5-ene-3 beta, 17 beta diol, Androstenedione, Testosterone and Dihydrotestosterone in Postmenopausal Women Serum by a Robust LC-MS/MS Validated Assay using a Single Sample Preparation Method. Steroids, . https://doi.org/10.1016/j.steroids.2014.08.001
Ke, Yuyong, et al. "WITHDRAWN: Sensitive and Accurate Simultaneous Measurement of Estrone, Estradiol, Dehydroepiandrosterone, Androst-5-ene-3 beta, 17 beta diol, Androstenedione, Testosterone and Dihydrotestosterone in Postmenopausal Women Serum by a Robust LC-MS/MS Validated Assay using a Single Sample Preparation Method." Steroids vol. (2014). doi: https://doi.org/10.1016/j.steroids.2014.08.001
Ke Y, Bertin J, Gonthier R, Simard JN, Labrie F. WITHDRAWN: Sensitive and Accurate Simultaneous Measurement of Estrone, Estradiol, Dehydroepiandrosterone, Androst-5-ene-3 beta, 17 beta diol, Androstenedione, Testosterone and Dihydrotestosterone in Postmenopausal Women Serum by a Robust LC-MS/MS Validated Assay using a Single Sample Preparation Method. Steroids. 2014 Aug 23; doi: 10.1016/j.steroids.2014.08.001. Epub 2014 Aug 23. PMID: 25159106.
Copy Download .nbib Format: NLM
Congenital Adrenal Hyperplasia due to 17-alpha-hydoxylase/17,20-lyase Deficiency Presenting with Hypertension and Pseudohermaphroditism: First Case Report from Oman.

Oman medical journal

Mula-Abed WA, Pambinezhuth FB, Al-Kindi MK, Al-Busaidi NB, Al-Muslahi HN, Al-Lamki MA.
PMID: 24498484
Oman Med J. 2014 Jan;29(1):55-9. doi: 10.5001/omj.2014.12.

This is the first report of congenital adrenal hyperplasia (CAH) due to combined 17α-hydroxylase/17,20 lyase deficiency in an Omani patient who was initially treated for many years as a case of hypertension. CAH is an uncommon disorder that results...

Cite
Mula-Abed WA, Pambinezhuth FB, Al-Kindi MK, et al. Congenital Adrenal Hyperplasia due to 17-alpha-hydoxylase/17,20-lyase Deficiency Presenting with Hypertension and Pseudohermaphroditism: First Case Report from Oman. Oman Med J. 2014;29(1):55-9doi: 10.5001/omj.2014.12.
Mula-Abed, W. A., Pambinezhuth, F. B., Al-Kindi, M. K., Al-Busaidi, N. B., Al-Muslahi, H. N., & Al-Lamki, M. A. (2014). Congenital Adrenal Hyperplasia due to 17-alpha-hydoxylase/17,20-lyase Deficiency Presenting with Hypertension and Pseudohermaphroditism: First Case Report from Oman. Oman medical journal, 29(1), 55-9. https://doi.org/10.5001/omj.2014.12
Mula-Abed, Waad-Allah S, et al. "Congenital Adrenal Hyperplasia due to 17-alpha-hydoxylase/17,20-lyase Deficiency Presenting with Hypertension and Pseudohermaphroditism: First Case Report from Oman." Oman medical journal vol. 29,1 (2014): 55-9. doi: https://doi.org/10.5001/omj.2014.12
Mula-Abed WA, Pambinezhuth FB, Al-Kindi MK, Al-Busaidi NB, Al-Muslahi HN, Al-Lamki MA. Congenital Adrenal Hyperplasia due to 17-alpha-hydoxylase/17,20-lyase Deficiency Presenting with Hypertension and Pseudohermaphroditism: First Case Report from Oman. Oman Med J. 2014 Jan;29(1):55-9. doi: 10.5001/omj.2014.12. PMID: 24498484; PMCID: PMC3910417.
Copy Download .nbib Format: NLM
Transformation of steroids by axillary coryneform bacteria.

International journal of cosmetic science

Gower DB, Nixon A, Jackman PJ, Mallett AI.
PMID: 19457213
Int J Cosmet Sci. 1986 Aug;8(4):149-58. doi: 10.1111/j.1467-2494.1986.tb00443.x.

Synopsis The contribution made by the apocrine glands to body odour has been discussed. In particular, the role of odorous steroids, such as 5alpha-androst-16-en-3-one (5alpha-A), and their formation by axillary bacteria, has been explored. Isotopically labelled testosterone was incubated...

Cite
Gower DB, Nixon A, Jackman PJ, et al. Transformation of steroids by axillary coryneform bacteria. Int J Cosmet Sci. 1986;8(4):149-58doi: 10.1111/j.1467-2494.1986.tb00443.x.
Gower, D. B., Nixon, A., Jackman, P. J., & Mallett, A. I. (1986). Transformation of steroids by axillary coryneform bacteria. International journal of cosmetic science, 8(4), 149-58. https://doi.org/10.1111/j.1467-2494.1986.tb00443.x
Gower, D B, et al. "Transformation of steroids by axillary coryneform bacteria." International journal of cosmetic science vol. 8,4 (1986): 149-58. doi: https://doi.org/10.1111/j.1467-2494.1986.tb00443.x
Gower DB, Nixon A, Jackman PJ, Mallett AI. Transformation of steroids by axillary coryneform bacteria. Int J Cosmet Sci. 1986 Aug;8(4):149-58. doi: 10.1111/j.1467-2494.1986.tb00443.x. PMID: 19457213.
Copy Download .nbib Format: NLM
Detrimental effects of endogenous oestrogens on primary acute myocardial infarction among postmenopausal women.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Dong M, Guo F, Yang J, Liu S, Tao Z, Fang Y, Zhang C, Li J, Li G.
PMID: 23055054
Neth Heart J. 2013 Apr;21(4):175-80. doi: 10.1007/s12471-012-0323-5.

OBJECTIVE: Traditionally, oestrogens were considered to be protective for the cardiovascular system for premenopausal women. Therefore, we conducted a retrospective case-control study to examine the association between endogenous oestrogens and acute myocardial infarction (AMI) risk among postmenopausal women.METHODS: A...

Cite
Dong M, Guo F, Yang J, et al. Detrimental effects of endogenous oestrogens on primary acute myocardial infarction among postmenopausal women. Neth Heart J. 2013;21(4):175-80doi: 10.1007/s12471-012-0323-5.
Dong, M., Guo, F., Yang, J., Liu, S., Tao, Z., Fang, Y., Zhang, C., Li, J., & Li, G. (2013). Detrimental effects of endogenous oestrogens on primary acute myocardial infarction among postmenopausal women. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 21(4), 175-80. https://doi.org/10.1007/s12471-012-0323-5
Dong, M, et al. "Detrimental effects of endogenous oestrogens on primary acute myocardial infarction among postmenopausal women." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 21,4 (2013): 175-80. doi: https://doi.org/10.1007/s12471-012-0323-5
Dong M, Guo F, Yang J, Liu S, Tao Z, Fang Y, Zhang C, Li J, Li G. Detrimental effects of endogenous oestrogens on primary acute myocardial infarction among postmenopausal women. Neth Heart J. 2013 Apr;21(4):175-80. doi: 10.1007/s12471-012-0323-5. PMID: 23055054; PMCID: PMC3673596.
Copy Download .nbib Format: NLM
Amniotic Fluid INSL3 Measured During the Critical Time Window in Human Pregnancy Relates to Cryptorchidism, Hypospadias, and Phthalate Load: A Large Case-Control Study.

Frontiers in physiology

Anand-Ivell R, Cohen A, Nørgaard-Pedersen B, Jönsson BAG, Bonde JP, Hougaard DM, Lindh CH, Toft G, Lindhard MS, Ivell R.
PMID: 29740335
Front Physiol. 2018 Apr 24;9:406. doi: 10.3389/fphys.2018.00406. eCollection 2018.

The period of the first to second trimester transition in human pregnancy represents a sensitive window for fetal organogenesis, particularly in regard to the development of the male reproductive system. This is a time of relative analytical inaccessibility. We...

Cite
Anand-Ivell R, Cohen A, Nørgaard-Pedersen B, et al. Amniotic Fluid INSL3 Measured During the Critical Time Window in Human Pregnancy Relates to Cryptorchidism, Hypospadias, and Phthalate Load: A Large Case-Control Study. Front Physiol. 2018;9:406doi: 10.3389/fphys.2018.00406.
Anand-Ivell, R., Cohen, A., Nørgaard-Pedersen, B., Jönsson, B. A. G., Bonde, J. P., Hougaard, D. M., Lindh, C. H., Toft, G., Lindhard, M. S., & Ivell, R. (2018). Amniotic Fluid INSL3 Measured During the Critical Time Window in Human Pregnancy Relates to Cryptorchidism, Hypospadias, and Phthalate Load: A Large Case-Control Study. Frontiers in physiology, 9406. https://doi.org/10.3389/fphys.2018.00406
Anand-Ivell, Ravinder, et al. "Amniotic Fluid INSL3 Measured During the Critical Time Window in Human Pregnancy Relates to Cryptorchidism, Hypospadias, and Phthalate Load: A Large Case-Control Study." Frontiers in physiology vol. 9 (2018): 406. doi: https://doi.org/10.3389/fphys.2018.00406
Anand-Ivell R, Cohen A, Nørgaard-Pedersen B, Jönsson BAG, Bonde JP, Hougaard DM, Lindh CH, Toft G, Lindhard MS, Ivell R. Amniotic Fluid INSL3 Measured During the Critical Time Window in Human Pregnancy Relates to Cryptorchidism, Hypospadias, and Phthalate Load: A Large Case-Control Study. Front Physiol. 2018 Apr 24;9:406. doi: 10.3389/fphys.2018.00406. eCollection 2018. PMID: 29740335; PMCID: PMC5928321.
Copy Download .nbib Format: NLM
Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach.

Frontiers in endocrinology

Albini A, Bruno A, Bassani B, D'Ambrosio G, Pelosi G, Consonni P, Castellani L, Conti M, Cristoni S, Noonan DM.
PMID: 29674995
Front Endocrinol (Lausanne). 2018 Apr 05;9:110. doi: 10.3389/fendo.2018.00110. eCollection 2018.

BACKGROUND: Serum steroids are crucial molecules altered in prostate cancer (PCa). Mass spectrometry (MS) is currently the elected technology for the analysis of steroids in diverse biological samples. Steroids have complex biological pathways and stoichiometry and it is important...

Cite
Albini A, Bruno A, Bassani B, et al. Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach. Front Endocrinol (Lausanne). 2018;9:110doi: 10.3389/fendo.2018.00110.
Albini, A., Bruno, A., Bassani, B., D'Ambrosio, G., Pelosi, G., Consonni, P., Castellani, L., Conti, M., Cristoni, S., & Noonan, D. M. (2018). Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach. Frontiers in endocrinology, 9110. https://doi.org/10.3389/fendo.2018.00110
Albini, Adriana, et al. "Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach." Frontiers in endocrinology vol. 9 (2018): 110. doi: https://doi.org/10.3389/fendo.2018.00110
Albini A, Bruno A, Bassani B, D'Ambrosio G, Pelosi G, Consonni P, Castellani L, Conti M, Cristoni S, Noonan DM. Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach. Front Endocrinol (Lausanne). 2018 Apr 05;9:110. doi: 10.3389/fendo.2018.00110. eCollection 2018. PMID: 29674995; PMCID: PMC5895774.
Copy Download .nbib Format: NLM
Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system.

Research and reports in urology

Pais P, Villar A, Rull S.
PMID: 27186566
Res Rep Urol. 2016 Apr 21;8:41-9. doi: 10.2147/RRU.S96576. eCollection 2016.

BACKGROUND: The nicotinamide adenine dinucleotide phosphate-dependent membrane protein 5α-reductase catalyses the conversion of testosterone to the most potent androgen - 5α-dihydrotestosterone. Two 5α-reductase isoenzymes are expressed in humans: type I and type II. The latter is found primarily in...

Cite
Pais P, Villar A, Rull S. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system. Res Rep Urol. 2016;8:41-9doi: 10.2147/RRU.S96576.
Pais, P., Villar, A., & Rull, S. (2016). Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system. Research and reports in urology, 841-9. https://doi.org/10.2147/RRU.S96576
Pais, Pilar, et al. "Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system." Research and reports in urology vol. 8 (2016): 41-9. doi: https://doi.org/10.2147/RRU.S96576
Pais P, Villar A, Rull S. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system. Res Rep Urol. 2016 Apr 21;8:41-9. doi: 10.2147/RRU.S96576. eCollection 2016. PMID: 27186566; PMCID: PMC4847595.
Copy Download .nbib Format: NLM
Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.

Frontiers in pharmacology

Udhane SS, Parween S, Kagawa N, Pandey AV.
PMID: 28970799
Front Pharmacol. 2017 Aug 25;8:580. doi: 10.3389/fphar.2017.00580. eCollection 2017.

All cytochromes P450s in the endoplasmic reticulum rely on P450 oxidoreductase (POR) for their catalytic activities. Mutations in POR cause metabolic disorders of steroid hormone biosynthesis and affect certain drug metabolizing P450 activities. We studied mutations A115V, T142A, Q153R...

Cite
Udhane SS, Parween S, Kagawa N, et al. Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase. Front Pharmacol. 2017;8:580doi: 10.3389/fphar.2017.00580.
Udhane, S. S., Parween, S., Kagawa, N., & Pandey, A. V. (2017). Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase. Frontiers in pharmacology, 8580. https://doi.org/10.3389/fphar.2017.00580
Udhane, Sameer S, et al. "Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase." Frontiers in pharmacology vol. 8 (2017): 580. doi: https://doi.org/10.3389/fphar.2017.00580
Udhane SS, Parween S, Kagawa N, Pandey AV. Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase. Front Pharmacol. 2017 Aug 25;8:580. doi: 10.3389/fphar.2017.00580. eCollection 2017. PMID: 28970799; PMCID: PMC5609582.
Copy Download .nbib Format: NLM
Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.

Molecular and clinical oncology

Bush SH, Tollin S, Marchion DC, Xiong Y, Abbasi F, Ramirez IJ, Zgheib NB, Boac B, Judson PL, Chon HS, Wenham RM, Apte SM, Cubitt CL, Berglund AE, Havrilesky LJ, Lancaster JM.
PMID: 26998291
Mol Clin Oncol. 2016 Mar;4(3):399-404. doi: 10.3892/mco.2016.725. Epub 2016 Jan 07.

Experimental and epidemiological data support the potential activity of acetaminophen against ovarian cancer (OVCA). In this study, we sought to confirm the activity of acetaminophen in OVCA cell lines and to investigate the molecular basis of response. A total...

Cite
Bush SH, Tollin S, Marchion DC, et al. Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival. Mol Clin Oncol. 2016;4(3):399-404doi: 10.3892/mco.2016.725.
Bush, S. H., Tollin, S., Marchion, D. C., Xiong, Y., Abbasi, F., Ramirez, I. J., Zgheib, N. B., Boac, B., Judson, P. L., Chon, H. S., Wenham, R. M., Apte, S. M., Cubitt, C. L., Berglund, A. E., Havrilesky, L. J., & Lancaster, J. M. (2016). Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival. Molecular and clinical oncology, 4(3), 399-404. https://doi.org/10.3892/mco.2016.725
Bush, Stephen H, et al. "Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival." Molecular and clinical oncology vol. 4,3 (2016): 399-404. doi: https://doi.org/10.3892/mco.2016.725
Bush SH, Tollin S, Marchion DC, Xiong Y, Abbasi F, Ramirez IJ, Zgheib NB, Boac B, Judson PL, Chon HS, Wenham RM, Apte SM, Cubitt CL, Berglund AE, Havrilesky LJ, Lancaster JM. Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival. Mol Clin Oncol. 2016 Mar;4(3):399-404. doi: 10.3892/mco.2016.725. Epub 2016 Jan 07. PMID: 26998291; PMCID: PMC4774474.
Copy Download .nbib Format: NLM
Prediction of Responsiveness to Clomiphene Citrate in Infertile Women with PCOS.

Journal of reproduction & infertility

Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S.
PMID: 31423417
J Reprod Infertil. 2019 Jul-Sep;20(3):143-150.

BACKGROUND: The purpose of the study was to evaluate the role of clinical, metabolic, hormonal and ultrasound features of women with PCOS in predicting the response to clomiphene citrate in treatment of infertility.METHODS: A prospective observational study was done...

Cite
Sachdeva G, Gainder S, Suri V, et al. Prediction of Responsiveness to Clomiphene Citrate in Infertile Women with PCOS. J Reprod Infertil. 2019;20(3):143-150
Sachdeva, G., Gainder, S., Suri, V., Sachdeva, N., & Chopra, S. (2019). Prediction of Responsiveness to Clomiphene Citrate in Infertile Women with PCOS. Journal of reproduction & infertility, 20(3), 143-150.
Sachdeva, Garima, et al. "Prediction of Responsiveness to Clomiphene Citrate in Infertile Women with PCOS." Journal of reproduction & infertility vol. 20,3 (2019): 143-150.
Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Prediction of Responsiveness to Clomiphene Citrate in Infertile Women with PCOS. J Reprod Infertil. 2019 Jul-Sep;20(3):143-150. PMID: 31423417; PMCID: PMC6670260.
Copy Download .nbib Format: NLM
Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease.

Journal of medical biochemistry

Blagojevic IP, Eror T, Pelivanovic J, Jelic S, Kotur-Stevuljevic J, Ignjatovic S.
PMID: 30568543
J Med Biochem. 2017 Jul 14;36(3):259-269. doi: 10.1515/jomb-2017-0020. eCollection 2017 Sep.

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with reproductive and metabolic abnormalities. The aim of this study was to analyse risk of cardiovascular disease (CVD) in PCOS, to define individual risk factors and assess their ability to predict risk.METHODS:...

Cite
Blagojevic IP, Eror T, Pelivanovic J, et al. Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease. J Med Biochem. 2017;36(3):259-269doi: 10.1515/jomb-2017-0020.
Blagojevic, I. P., Eror, T., Pelivanovic, J., Jelic, S., Kotur-Stevuljevic, J., & Ignjatovic, S. (2017). Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease. Journal of medical biochemistry, 36(3), 259-269. https://doi.org/10.1515/jomb-2017-0020
Blagojevic, Iva Perovic, et al. "Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease." Journal of medical biochemistry vol. 36,3 (2017): 259-269. doi: https://doi.org/10.1515/jomb-2017-0020
Blagojevic IP, Eror T, Pelivanovic J, Jelic S, Kotur-Stevuljevic J, Ignjatovic S. Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease. J Med Biochem. 2017 Jul 14;36(3):259-269. doi: 10.1515/jomb-2017-0020. eCollection 2017 Sep. PMID: 30568543; PMCID: PMC6287215.
Copy Download .nbib Format: NLM
Androstenedione changes steroidogenic activity of SGBS cells.

Endocrine connections

Ernst J, Gert K, Kraus FB, Rolle-Kampczyk UE, Wabitsch M, Dehghani F, Schaedlich K.
PMID: 32580160
Endocr Connect. 2020 Jul;9(7):587-598. doi: 10.1530/EC-19-0549.

The rapid increase of obesity during the last decades and its future prospects are alarming. Besides the general discussed causes of obesity, the 'Developmental Origins of Health and Disease' (DOHaD) hypothesis received more attention in recent years. This hypothesis...

Cite
Ernst J, Gert K, Kraus FB, et al. Androstenedione changes steroidogenic activity of SGBS cells. Endocr Connect. 2020;9(7):587-598doi: 10.1530/EC-19-0549.
Ernst, J., Gert, K., Kraus, F. B., Rolle-Kampczyk, U. E., Wabitsch, M., Dehghani, F., & Schaedlich, K. (2020). Androstenedione changes steroidogenic activity of SGBS cells. Endocrine connections, 9(7), 587-598. https://doi.org/10.1530/EC-19-0549
Ernst, Jana, et al. "Androstenedione changes steroidogenic activity of SGBS cells." Endocrine connections vol. 9,7 (2020): 587-598. doi: https://doi.org/10.1530/EC-19-0549
Ernst J, Gert K, Kraus FB, Rolle-Kampczyk UE, Wabitsch M, Dehghani F, Schaedlich K. Androstenedione changes steroidogenic activity of SGBS cells. Endocr Connect. 2020 Jul;9(7):587-598. doi: 10.1530/EC-19-0549. PMID: 32580160; PMCID: PMC7354720.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 443 entries